1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Disease Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Disease Market, Canada
2.1 Cardiac Disease Market, Canada, Revenue ($m), 2024-2036
2.1.1 Cardiac Marker Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Disease Market, Canada, Volume (Units), 2024-2036
2.2.1 Cardiac Marker Tests Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Disease Market, Canada, Average Price ($), 2024-2036
2.4 Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2025
3 Cardiac Disease Market Pipeline Products
3.1 Cardiac Disease Market Pipeline Products
3.2 Cardiac Disease - Pipeline Products by Stage of Development
3.3 Cardiac Disease - Pipeline Products by Segment
3.4 Cardiac Disease - Pipeline Products by Territory
3.5 Cardiac Disease - Pipeline Products by Regulatory Path
3.6 Cardiac Disease - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Cardiac Disease Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Siemens Healthineers AG
4.3.1 Company Overview
4.4 Quidel Corp
4.4.1 Company Overview
4.5 Beckman Coulter Inc
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
5 Recent Developments
5.1 Other Significant Developments
5.1.1 Nov 24, 2025: AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
5.2 Product News
5.2.1 Mar 12, 2026: PsyMetRiC: Tool to Predict Physical Health Risks in Young People With Psychosis
5.2.2 Oct 27, 2025: University of Alberta: Some Cancer Patients Get Heart Damage During Chemotherapy and Some Don’t
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Disease Market, Canada, Volume (Units), 2024-2036
Table 4: Cardiac Marker Tests Market, Canada, Volume (Units), 2024-2036
Table 5: Cardiac Disease Market, Canada, Average Price ($), 2024-2036
Table 6: Cardiac Disease Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Cardiac Disease Market Pipeline Products
Table 8: Cardiac Disease - Pipeline Products by Stage of Development
Table 9: Cardiac Disease Companies - Pipeline Products by Stage of Development
Table 10: Cardiac Disease - Pipeline Products by Segment
Table 11: Cardiac Disease - Pipeline Products by Territory
Table 12: Cardiac Disease - Pipeline Products by Regulatory Path
Table 13: Cardiac Disease - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Disease Market, Canada, Volume (Units), 2024-2036
Figure 4: Cardiac Marker Tests Market, Canada, Volume (Units), 2024-2036
Figure 5: Cardiac Disease Market, Canada, Company Share (%), 2025
Figure 6: Cardiac Disease - Pipeline Products by Stage of Development
Figure 7: Cardiac Disease - Pipeline Products by Segment
Figure 8: Cardiac Disease - Pipeline Products by Territory
Figure 9: Cardiac Disease - Pipeline Products by Regulatory Path
Figure 10: Cardiac Disease - Pipeline Products by Estimated Approval Date